Protalix BioTherapeutics, Inc. Stock TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 168M 0 145M 134M 125M 235M 16.01B 239M 1.58B 617M 7.79B 632M 619M 26.98B | P/E Ratio 2026 * |
10.7x | P/E Ratio 2027 * | 41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 168M 0 145M 134M 125M 235M 16.01B 239M 1.58B 617M 7.79B 632M 619M 26.98B | EV / Sales 2026 * |
2.15x | EV / Sales 2027 * | 2.49x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 58 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 58 | 2025-08-23 |
Shoshi Tessler
CTO | Chief Tech/Sci/R&D Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Pol Boudes
BRD | Director/Board Member | 68 | 2019-11-30 |
Gwen Melincoff
BRD | Director/Board Member | 73 | 2019-11-30 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 2014-10-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 165M | |
| -2.41% | +0.14% | +39.53% | +154.43% | 1,035B | |
| +1.07% | +3.48% | +53.75% | +50.64% | 574B | |
| +1.32% | +0.22% | +18.35% | +65.35% | 397B | |
| +0.77% | 0.00% | +19.99% | +16.80% | 324B | |
| -1.42% | -1.44% | +45.50% | +8.37% | 298B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 281B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 278B | |
| +1.66% | +1.20% | -44.67% | -47.49% | 193B | |
| +0.32% | +1.61% | +19.48% | +63.42% | 191B | |
| Average | -0.25% | +0.96% | +22.05% | +39.97% | 396.88B | |
| Weighted average by Cap. | -0.82% | +1.00% | +30.01% | +66.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 0 67.63M 62.32M 58.33M 109M 7.44B 111M 736M 287M 3.62B 294M 288M 12.54B | 67.56M 0 58.36M 53.77M 50.34M 94.33M 6.42B 95.79M 635M 248M 3.13B 254M 248M 10.82B |
| Net income | 15.72M 0 13.58M 12.51M 11.71M 21.95M 1.49B 22.29M 148M 57.61M 727M 59.01M 57.75M 2.52B | 4.07M 0 3.52M 3.24M 3.03M 5.69M 387M 5.78M 38.28M 14.93M 188M 15.29M 14.96M 653M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
